Skip to content
drillr.ai
Sign up

603168.SH

Zhejiang Shapuaisi Pharmaceutical Co. Ltd.

SSE · Healthcare · Medical - Pharmaceuticals · CN

CNY 5.48
+0.55%
Ask drillr

  • Sep 21, 2026, 09:03 UTC

    Shareholder Chen Dekang plans to reduce his stake in Zhejiang Shapuaisi Pharmaceutical by up to 1% of total shares via centralized bidding between October 21, 2026 and January 20, 2027.

  • Aug 30, 2026, 07:36 UTC

    Shapuaisi announced its first-half 2026 results with revenue of 197 million yuan, down 16.77% year-on-year, and net profit attributable to shareholders of 19.5 million yuan, down 10.81% year-on-year.

    Source: